Cargando…
Efficacy and safety of Lianhua Qingwen capsules, a repurposed Chinese herb, in patients with Coronavirus disease 2019: A multicenter, prospective, randomized controlled trial [Phytomedicine 85 (2021) 153242]
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier GmbH.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805149/ https://www.ncbi.nlm.nih.gov/pubmed/34775361 http://dx.doi.org/10.1016/j.phymed.2021.153800 |
_version_ | 1784643184145465344 |
---|---|
author | Hu, Ke Guan, Wei-jie Bi, Ying Zhang, Wei Li, Lanjuan Zhang, Boli Liu, Qingquan Song, Yuanlin Li, Xingwang Duan, Zhongping Zheng, Qingshan Yang, Zifeng Liang, Jingyi Han, Mingfeng Ruan, Lianguo Wu, Chaomin Zhang, Yunting Jia, Zhen-hua Zhong, Nan-shan |
author_facet | Hu, Ke Guan, Wei-jie Bi, Ying Zhang, Wei Li, Lanjuan Zhang, Boli Liu, Qingquan Song, Yuanlin Li, Xingwang Duan, Zhongping Zheng, Qingshan Yang, Zifeng Liang, Jingyi Han, Mingfeng Ruan, Lianguo Wu, Chaomin Zhang, Yunting Jia, Zhen-hua Zhong, Nan-shan |
author_sort | Hu, Ke |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8805149 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier GmbH. |
record_format | MEDLINE/PubMed |
spelling | pubmed-88051492022-02-01 Efficacy and safety of Lianhua Qingwen capsules, a repurposed Chinese herb, in patients with Coronavirus disease 2019: A multicenter, prospective, randomized controlled trial [Phytomedicine 85 (2021) 153242] Hu, Ke Guan, Wei-jie Bi, Ying Zhang, Wei Li, Lanjuan Zhang, Boli Liu, Qingquan Song, Yuanlin Li, Xingwang Duan, Zhongping Zheng, Qingshan Yang, Zifeng Liang, Jingyi Han, Mingfeng Ruan, Lianguo Wu, Chaomin Zhang, Yunting Jia, Zhen-hua Zhong, Nan-shan Phytomedicine Corrigendum Elsevier GmbH. 2022-01 2021-10-09 /pmc/articles/PMC8805149/ /pubmed/34775361 http://dx.doi.org/10.1016/j.phymed.2021.153800 Text en © 2021 Elsevier GmbH. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Corrigendum Hu, Ke Guan, Wei-jie Bi, Ying Zhang, Wei Li, Lanjuan Zhang, Boli Liu, Qingquan Song, Yuanlin Li, Xingwang Duan, Zhongping Zheng, Qingshan Yang, Zifeng Liang, Jingyi Han, Mingfeng Ruan, Lianguo Wu, Chaomin Zhang, Yunting Jia, Zhen-hua Zhong, Nan-shan Efficacy and safety of Lianhua Qingwen capsules, a repurposed Chinese herb, in patients with Coronavirus disease 2019: A multicenter, prospective, randomized controlled trial [Phytomedicine 85 (2021) 153242] |
title | Efficacy and safety of Lianhua Qingwen capsules, a
repurposed Chinese herb, in patients with Coronavirus disease 2019: A
multicenter, prospective, randomized controlled trial [Phytomedicine 85 (2021)
153242] |
title_full | Efficacy and safety of Lianhua Qingwen capsules, a
repurposed Chinese herb, in patients with Coronavirus disease 2019: A
multicenter, prospective, randomized controlled trial [Phytomedicine 85 (2021)
153242] |
title_fullStr | Efficacy and safety of Lianhua Qingwen capsules, a
repurposed Chinese herb, in patients with Coronavirus disease 2019: A
multicenter, prospective, randomized controlled trial [Phytomedicine 85 (2021)
153242] |
title_full_unstemmed | Efficacy and safety of Lianhua Qingwen capsules, a
repurposed Chinese herb, in patients with Coronavirus disease 2019: A
multicenter, prospective, randomized controlled trial [Phytomedicine 85 (2021)
153242] |
title_short | Efficacy and safety of Lianhua Qingwen capsules, a
repurposed Chinese herb, in patients with Coronavirus disease 2019: A
multicenter, prospective, randomized controlled trial [Phytomedicine 85 (2021)
153242] |
title_sort | efficacy and safety of lianhua qingwen capsules, a
repurposed chinese herb, in patients with coronavirus disease 2019: a
multicenter, prospective, randomized controlled trial [phytomedicine 85 (2021)
153242] |
topic | Corrigendum |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805149/ https://www.ncbi.nlm.nih.gov/pubmed/34775361 http://dx.doi.org/10.1016/j.phymed.2021.153800 |
work_keys_str_mv | AT huke efficacyandsafetyoflianhuaqingwencapsulesarepurposedchineseherbinpatientswithcoronavirusdisease2019amulticenterprospectiverandomizedcontrolledtrialphytomedicine852021153242 AT guanweijie efficacyandsafetyoflianhuaqingwencapsulesarepurposedchineseherbinpatientswithcoronavirusdisease2019amulticenterprospectiverandomizedcontrolledtrialphytomedicine852021153242 AT biying efficacyandsafetyoflianhuaqingwencapsulesarepurposedchineseherbinpatientswithcoronavirusdisease2019amulticenterprospectiverandomizedcontrolledtrialphytomedicine852021153242 AT zhangwei efficacyandsafetyoflianhuaqingwencapsulesarepurposedchineseherbinpatientswithcoronavirusdisease2019amulticenterprospectiverandomizedcontrolledtrialphytomedicine852021153242 AT lilanjuan efficacyandsafetyoflianhuaqingwencapsulesarepurposedchineseherbinpatientswithcoronavirusdisease2019amulticenterprospectiverandomizedcontrolledtrialphytomedicine852021153242 AT zhangboli efficacyandsafetyoflianhuaqingwencapsulesarepurposedchineseherbinpatientswithcoronavirusdisease2019amulticenterprospectiverandomizedcontrolledtrialphytomedicine852021153242 AT liuqingquan efficacyandsafetyoflianhuaqingwencapsulesarepurposedchineseherbinpatientswithcoronavirusdisease2019amulticenterprospectiverandomizedcontrolledtrialphytomedicine852021153242 AT songyuanlin efficacyandsafetyoflianhuaqingwencapsulesarepurposedchineseherbinpatientswithcoronavirusdisease2019amulticenterprospectiverandomizedcontrolledtrialphytomedicine852021153242 AT lixingwang efficacyandsafetyoflianhuaqingwencapsulesarepurposedchineseherbinpatientswithcoronavirusdisease2019amulticenterprospectiverandomizedcontrolledtrialphytomedicine852021153242 AT duanzhongping efficacyandsafetyoflianhuaqingwencapsulesarepurposedchineseherbinpatientswithcoronavirusdisease2019amulticenterprospectiverandomizedcontrolledtrialphytomedicine852021153242 AT zhengqingshan efficacyandsafetyoflianhuaqingwencapsulesarepurposedchineseherbinpatientswithcoronavirusdisease2019amulticenterprospectiverandomizedcontrolledtrialphytomedicine852021153242 AT yangzifeng efficacyandsafetyoflianhuaqingwencapsulesarepurposedchineseherbinpatientswithcoronavirusdisease2019amulticenterprospectiverandomizedcontrolledtrialphytomedicine852021153242 AT liangjingyi efficacyandsafetyoflianhuaqingwencapsulesarepurposedchineseherbinpatientswithcoronavirusdisease2019amulticenterprospectiverandomizedcontrolledtrialphytomedicine852021153242 AT hanmingfeng efficacyandsafetyoflianhuaqingwencapsulesarepurposedchineseherbinpatientswithcoronavirusdisease2019amulticenterprospectiverandomizedcontrolledtrialphytomedicine852021153242 AT ruanlianguo efficacyandsafetyoflianhuaqingwencapsulesarepurposedchineseherbinpatientswithcoronavirusdisease2019amulticenterprospectiverandomizedcontrolledtrialphytomedicine852021153242 AT wuchaomin efficacyandsafetyoflianhuaqingwencapsulesarepurposedchineseherbinpatientswithcoronavirusdisease2019amulticenterprospectiverandomizedcontrolledtrialphytomedicine852021153242 AT zhangyunting efficacyandsafetyoflianhuaqingwencapsulesarepurposedchineseherbinpatientswithcoronavirusdisease2019amulticenterprospectiverandomizedcontrolledtrialphytomedicine852021153242 AT jiazhenhua efficacyandsafetyoflianhuaqingwencapsulesarepurposedchineseherbinpatientswithcoronavirusdisease2019amulticenterprospectiverandomizedcontrolledtrialphytomedicine852021153242 AT zhongnanshan efficacyandsafetyoflianhuaqingwencapsulesarepurposedchineseherbinpatientswithcoronavirusdisease2019amulticenterprospectiverandomizedcontrolledtrialphytomedicine852021153242 |